牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

艾迪药业（688488）

5.3

综合诊断：5.3分打败了69%的股票！

卖出
减持
中性
增持
买入

短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
中期趋势：
下跌有所减缓，仍应保持谨慎。
长期趋势：
已有17家主力机构披露2025-12-31报告期持股数据，持仓量总计2172.81万股，占流通A股5.16%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

3.5分

6.6分

5.5分

2.5分

7.5分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：3.5技术面打败了16%的股票技术面评分前10的股票

近期的平均成本为17.02元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

技术面得分最高的股票

平均成本

近期的平均成本为17.02元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"17.02","date":1770279978,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。

[{"date":"2026.02.06","stock":"-2.21","trade":"0.22","ind":"-0.25"},{"date":"2026.02.05","stock":"2.93","trade":"-0.38","ind":"-0.64"},{"date":"2026.02.04","stock":"1.39","trade":"0.70","ind":"0.85"},{"date":"2026.02.03","stock":"3.38","trade":"1.66","ind":"1.29"},{"date":"2026.02.02","stock":"-3.80","trade":"-2.66","ind":"-2.48"},{"date":"2026.01.30","stock":"-2.64","trade":"-1.26","ind":"-0.96"},{"date":"2026.01.29","stock":"-2.57","trade":"-1.58","ind":"0.16"},{"date":"2026.01.28","stock":"-2.67","trade":"-2.31","ind":"0.27"},{"date":"2026.01.27","stock":"-3.02","trade":"-0.80","ind":"0.18"},{"date":"2026.01.26","stock":"-0.54","trade":"3.60","ind":"-0.09"},{"date":"2026.01.23","stock":"2.59","trade":"1.33","ind":"0.33"},{"date":"2026.01.22","stock":"-13.48","trade":"-0.59","ind":"0.14"},{"date":"2026.01.21","stock":"-2.33","trade":"0.19","ind":"0.08"},{"date":"2026.01.20","stock":"-2.98","trade":"-0.83","ind":"-0.01"},{"date":"2026.01.19","stock":"2.59","trade":"0.05","ind":"0.29"},{"date":"2026.01.16","stock":"2.96","trade":"-0.86","ind":"-0.26"},{"date":"2026.01.15","stock":"5.80","trade":"-1.14","ind":"-0.33"},{"date":"2026.01.14","stock":"16.72","trade":"-0.57","ind":"-0.31"},{"date":"2026.01.13","stock":"0.53","trade":"2.27","ind":"-0.64"},{"date":"2026.01.12","stock":"-4.41","trade":"0.29","ind":"1.09"},{"date":"2026.01.09","stock":"2.43","trade":"2.11","ind":"0.92"}]

艾迪药业,上证指数,生物制品指数

压力支撑

该股压力位为16.97元，支撑位为16.64元。

[{"text":"\u538b\u529b\u4f4d","value":"16.97","date":1770307200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"16.64","date":1770307200,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：6.6资金面打败了94%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码很集中，呈高度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：02月06日 20:31

机构今日流向(万元)	-3.24	机构5日流向(万元)	-4085.42
机构10日流向(万元)	-13652.83	机构20日流向(万元)	-27056.92

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少23239.49万股，其中基金净增仓4家，主力净减仓142家，暂未发现中长期投资价值。

截止2025-12-31，共17家主力机构（基金17家），持仓量总计2172.81万股，占流通A股5.16%
其中，基金持仓与2025-06-30相比：
增仓：4家，增持 111.38万股
减仓：0家，减持 0万股
新出现在主力名单中：13家，持有1889.7万股
从主力名单中消失：155家，原持有25240.57万股

消息面诊股

诊断结果：5.5消息面打败了69%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

利好	业绩预告	预计减亏	2026-01-26
一般消息	募资投向	公司购买资产	2026-01-14
利空	重大事项	公司违规：处罚类型	2026-01-14
一般消息	重大事项	关联交易	2026-01-01
一般消息	重大事项	关联交易	2025-10-16
一般消息	高管变动	取消监事会	2025-10-15
一般消息	股东大会	临时股东大会	2025-09-30
一般消息	高管变动	因达到法定退休年龄	2025-09-12
一般消息	分红转增	不分配不转增	2025-08-29
一般消息	高管变动	因个人原因	2025-07-14
一般消息	高管变动	辞去	2025-06-27
利空	重大事项	公司违规：处罚类型	2025-05-16
一般消息	分红转增	不分配不转增	2025-04-30

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	2条	0条	2条

行业面诊股

诊断结果：2.5行业面打败了32%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.02.06","price":"-0.25","value":"0.22"},{"date":"2026.02.05","price":"-0.64","value":"-0.38"},{"date":"2026.02.04","price":"0.85","value":"0.70"},{"date":"2026.02.03","price":"1.29","value":"1.66"},{"date":"2026.02.02","price":"-2.48","value":"-2.66"},{"date":"2026.01.30","price":"-0.96","value":"-1.26"},{"date":"2026.01.29","price":"0.16","value":"-1.58"},{"date":"2026.01.28","price":"0.27","value":"-2.31"},{"date":"2026.01.27","price":"0.18","value":"-0.80"},{"date":"2026.01.26","price":"-0.09","value":"3.60"},{"date":"2026.01.23","price":"0.33","value":"1.33"},{"date":"2026.01.22","price":"0.14","value":"-0.59"},{"date":"2026.01.21","price":"0.08","value":"0.19"},{"date":"2026.01.20","price":"-0.01","value":"-0.83"},{"date":"2026.01.19","price":"0.29","value":"0.05"},{"date":"2026.01.16","price":"-0.26","value":"-0.86"},{"date":"2026.01.15","price":"-0.33","value":"-1.14"},{"date":"2026.01.14","price":"-0.31","value":"-0.57"},{"date":"2026.01.13","price":"-0.64","value":"2.27"},{"date":"2026.01.12","price":"1.09","value":"0.29"},{"date":"2026.01.09","price":"0.92","value":"2.11"}]

上证指数,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	万泽股份	28.14%	-1.06%	6.1分
2	-	19.12%	2.92%	分
3	卫光生物	11.76%	7.80%	5.5分
4	华兰疫苗	10.44%	-0.18%	5.2分
5	赛伦生物	10.28%	2.74%	5.7分
6	优宁维	6.54%	2.58%	5.3分
7	诺诚健华	6.42%	12.24%	6.6分
8	*ST四环	5.67%	0.38%	5.2分
9	通化东宝	4.70%	-1.55%	5.5分
10	*ST双成	4.48%	6.44%	6.8分
11	东宝生物	3.19%	-0.16%	4.9分
12	昊帆生物	2.90%	3.03%	5.3分
13	荣昌生物	2.81%	-2.51%	5.5分
14	近岸蛋白	2.47%	-0.83%	4.2分
15	沃森生物	2.23%	-1.90%	4.4分
16	义翘神州	1.75%	-1.68%	4.8分
17	-	-0.17%	2.53%	分
18	赛升药业	-0.70%	2.71%	5.0分
19	华兰生物	-1.09%	-0.96%	4.8分
20	百克生物	-1.33%	-1.23%	4.4分
21	ST未名	-1.74%	-0.41%	4.5分
22	辽宁成大	-1.88%	-3.84%	4.7分
23	康泰生物	-2.38%	-0.38%	4.5分
24	诺唯赞	-2.43%	-0.33%	4.6分
25	上海莱士	-2.47%	0.16%	4.9分
26	安科生物	-2.63%	-0.50%	5.2分
27	天坛生物	-3.05%	-0.72%	5.1分
28	成大生物	-3.35%	-1.68%	4.7分
29	博晖创新	-3.45%	-3.02%	4.6分
30	康辰药业	-4.51%	6.65%	6.7分
31	艾迪药业	-4.69%	1.51%	5.3分
32	博雅生物	-4.81%	-2.57%	4.5分
33	西藏药业	-4.87%	0.87%	5.4分
34	派林生物	-5.09%	-0.51%	5.0分
35	康希诺	-5.11%	-5.04%	4.0分
36	金迪克	-5.12%	-1.26%	4.2分
37	三生国健	-5.30%	0.33%	6.8分
38	-	-6.21%	0.64%	分
39	百奥泰	-7.17%	0.94%	5.2分
40	甘李药业	-7.39%	-2.77%	4.6分
41	长春高新	-7.79%	-5.87%	3.9分
42	康华生物	-8.05%	-3.45%	4.7分
43	禾元生物	-8.34%	-3.88%	4.2分
44	科兴制药	-10.44%	-2.73%	5.3分
45	我武生物	-10.90%	-2.77%	4.5分
46	君实生物	-10.97%	-2.73%	4.6分
47	智飞生物	-11.77%	0.58%	4.8分
48	智翔金泰	-12.61%	0.21%	5.0分
49	特宝生物	-14.24%	-9.05%	4.6分
50	康弘药业	-15.23%	-0.85%	4.6分
51	百普赛斯	-15.86%	-10.75%	4.3分
52	神州细胞	-18.63%	-4.42%	4.4分
53	凯因科技	-18.84%	-0.59%	4.5分
54	迈威生物	-21.78%	-0.58%	4.5分
55	欧林生物	-23.95%	-2.08%	5.2分

<上一页 1 2 3 4 5...10 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：7.5基本面打败了97%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（30分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：较强，高于行业平均，两项指标的行业排名分别为 36/71 ， 32/71。

[{"date":"2025-09-30","value":"-0.70","vol":"-9.78"},{"date":"2025-06-30","value":"0.93","vol":"-0.61"},{"date":"2025-03-31","value":"1.58","vol":"0.46"},{"date":"2024-12-31","value":"-13.41","vol":"-0.68"},{"date":"2024-09-30","value":"-5.55","vol":"1.34"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	-0.70	0.93	1.58	-13.41	-5.55
行业(%)	-9.78	-0.61	0.46	-0.68	1.34

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"65.72","vol":"67.61"},{"date":"2025-06-30","value":"65.58","vol":"68.28"},{"date":"2025-03-31","value":"62.04","vol":"68.43"},{"date":"2024-12-31","value":"54.93","vol":"69.85"},{"date":"2024-09-30","value":"52.81","vol":"70.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	65.72	65.58	62.04	54.93	52.81
行业(%)	67.61	68.28	68.43	69.85	70.47

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，居行业前列，两项指标的行业排名分别为 5/71 ， 8/71。

[{"date":"2025-09-30","value":"84.83","vol":"45.25"},{"date":"2025-06-30","value":"100.19","vol":"6902.04"},{"date":"2025-03-31","value":"113.00","vol":"6125.27"},{"date":"2024-12-31","value":"1.57","vol":"47.35"},{"date":"2024-09-30","value":"-0.89","vol":"175.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	84.83	100.19	113.00	1.57	-0.89
行业(%)	45.25	6902.04	6125.27	47.35	175.00

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"88.78","vol":"44.80"},{"date":"2025-06-30","value":"120.23","vol":"5.44"},{"date":"2025-03-31","value":"214.52","vol":"-8.46"},{"date":"2024-12-31","value":"-85.63","vol":"-9.81"},{"date":"2024-09-30","value":"-87.75","vol":"-52.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	88.78	120.23	214.52	-85.63	-87.75
行业(%)	44.80	5.44	-8.46	-9.81	-52.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，两项指标的行业排名分别为 14/71 ， 23/71。

[{"date":"2025-09-30","value":"0.30","vol":"0.22"},{"date":"2025-06-30","value":"0.19","vol":"0.14"},{"date":"2025-03-31","value":"0.11","vol":"0.06"},{"date":"2024-12-31","value":"0.23","vol":"0.29"},{"date":"2024-09-30","value":"0.16","vol":"0.22"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.30	0.19	0.11	0.23	0.16
行业(次)	0.22	0.14	0.06	0.29	0.22

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.76","vol":"0.92"},{"date":"2025-06-30","value":"0.48","vol":"0.56"},{"date":"2025-03-31","value":"0.29","vol":"0.26"},{"date":"2024-12-31","value":"0.86","vol":"1.17"},{"date":"2024-09-30","value":"0.66","vol":"0.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	0.76	0.48	0.29	0.86	0.66
行业(次)	0.92	0.56	0.26	1.17	0.86

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"1.60","vol":"1.84"},{"date":"2025-06-30","value":"-9.30","vol":"-1377.61"},{"date":"2025-03-31","value":"20.09","vol":"-46.99"},{"date":"2024-12-31","value":"-30.75","vol":"-11.33"},{"date":"2024-09-30","value":"65.73","vol":"-30.88"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	1.60	-9.30	20.09	-30.75	65.73
行业	1.84	-1377.61	-46.99	-11.33	-30.88

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.54","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.79","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.54	-	0.79	-
行业	0.00	1.59	0.00	2.01	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 6/71 ， 1/71。

[{"date":"2025-09-30","value":"1.42","vol":"6.00"},{"date":"2025-06-30","value":"1.40","vol":"6.64"},{"date":"2025-03-31","value":"1.41","vol":"7.75"},{"date":"2024-12-31","value":"1.38","vol":"6.72"},{"date":"2024-09-30","value":"1.51","vol":"7.02"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	1.42	1.40	1.41	1.38	1.51
行业	6.00	6.64	7.75	6.72	7.02

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.00","vol":"4.84"},{"date":"2025-06-30","value":"0.99","vol":"5.30"},{"date":"2025-03-31","value":"0.97","vol":"6.35"},{"date":"2024-12-31","value":"0.96","vol":"5.40"},{"date":"2024-09-30","value":"1.06","vol":"5.66"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	1.00	0.99	0.97	0.96	1.06
行业	4.84	5.30	6.35	5.40	5.66

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 6/71 ， 11/71。

[{"date":"2025-09-30","value":"41.35","vol":"28.18"},{"date":"2025-06-30","value":"43.34","vol":"26.73"},{"date":"2025-03-31","value":"42.35","vol":"26.03"},{"date":"2024-12-31","value":"42.92","vol":"25.81"},{"date":"2024-09-30","value":"40.23","vol":"24.44"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	41.35	43.34	42.35	42.92	40.23
行业(%)	28.18	26.73	26.03	25.81	24.44

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.78","vol":"0.58"},{"date":"2025-06-30","value":"0.84","vol":"1.11"},{"date":"2025-03-31","value":"0.81","vol":"0.78"},{"date":"2024-12-31","value":"0.82","vol":"0.87"},{"date":"2024-09-30","value":"0.73","vol":"0.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.78	0.84	0.81	0.82	0.73
行业(%)	0.58	1.11	0.78	0.87	0.40

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
申万宏源	2026-01-14	买入

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"-0.30","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-1.24","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-0.76","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-1.41","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.07","blueLineValue":"0.02","type":"YC"}]

[艾迪药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]